Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19

被引:0
|
作者
Taha Baghbani
Hossein Nikzad
Javid Azadbakht
Fatemeh Izadpanah
Hamed Haddad Kashani
机构
[1] Kashan University of Medical Sciences,Anatomical Sciences Research Center, Institute for Basic Sciences
[2] Kashan University of Medical Sciences,Department of Radiology, Faculty of Medicin
[3] Food & Drug Administration of Iran,Food and Drug Laboratory Research Center and Food and Drug Reference Control Laboratories Center
[4] MOH & ME,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
All of humans and other mammalian species are colonized by some types of microorganisms such as bacteria, archaea, unicellular eukaryotes like fungi and protozoa, multicellular eukaryotes like helminths, and viruses, which in whole are called microbiota. These microorganisms have multiple different types of interaction with each other. A plethora of evidence suggests that they can regulate immune and digestive systems and also play roles in various diseases, such as mental, cardiovascular, metabolic and some skin diseases. In addition, they take-part in some current health problems like diabetes mellitus, obesity, cancers and infections. Viral infection is one of the most common and problematic health care issues, particularly in recent years that pandemics like SARS and COVID-19 caused a lot of financial and physical damage to the world. There are plenty of articles investigating the interaction between microbiota and infectious diseases. We focused on stimulatory to suppressive effects of microbiota on viral infections, hoping to find a solution to overcome this current pandemic. Then we reviewed mechanistically the effects of both microbiota and probiotics on most of the viruses. But unlike previous studies which concentrated on intestinal microbiota and infection, our focus is on respiratory system’s microbiota and respiratory viral infection, bearing in mind that respiratory system is a proper entry site and residence for viruses, and whereby infection, can lead to asymptomatic, mild, self-limiting, severe or even fatal infection. Finally, we overgeneralize the effects of microbiota on COVID-19 infection. In addition, we reviewed the articles about effects of the microbiota on coronaviruses and suggest some new therapeutic measures.
引用
收藏
相关论文
共 50 条
  • [41] Reassessing the Landscape of Viral Respiratory Infections After the COVID-19 Pandemic
    Generali, Elena
    Aliberti, Stefano
    Cecconi, Maurizio
    Voza, Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2025, 61 (03): : 125 - 126
  • [42] NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
    Capuano, Annalisa
    Scavone, Cristina
    Racagni, Giorgio
    Scaglione, Francesco
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [43] Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists
    Yuen, Erick
    Gudis, David A.
    Rowan, Nicholas R.
    Nguyen, Shaun A.
    Schlosser, Rodney J.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2021, 35 (01) : 122 - 131
  • [44] Respiratory viral infections including COVID-19 in solid organ transplantation
    Lo, Carson K. L.
    Kumar, Deepali
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2023, 28 (06) : 471 - 482
  • [45] Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19
    Smilowitz, Nathaniel R.
    Subashchandran, Varun
    Yuriditsky, Eugene
    Horowitz, James M.
    Reynolds, Harmony R.
    Hochman, Judith S.
    Berger, Jeffrey S.
    AMERICAN HEART JOURNAL, 2021, 231 : 93 - 95
  • [46] How COVID-19 will change the management of other respiratory viral infections
    Yaseen M. Arabi
    Lennie P. G. Derde
    Jean-François Timsit
    Intensive Care Medicine, 2021, 47 : 1148 - 1151
  • [47] Enhancing immunity in viral infections, with special emphasis on COVID-19: A review
    Jayawardena, Ranil
    Sooriyaarachchi, Piumika
    Chourdakis, Michail
    Jeewandara, Chandima
    Ranasinghe, Priyanga
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 367 - 382
  • [48] How COVID-19 will change the management of other respiratory viral infections
    Arabi, Yaseen M.
    Derde, Lennie P. G.
    Timsit, Jean-Francois
    INTENSIVE CARE MEDICINE, 2021, 47 (10) : 1148 - 1151
  • [49] The Importance of Monitoring Viral Respiratory Infections During the COVID-19 Crisis
    Hamamoto, Itsuki
    Shimasaki, Noriko
    JOURNAL OF DISASTER RESEARCH, 2022, 17 (01) : 73 - 81
  • [50] Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution
    Megarbane, Bruno
    CLINICAL TOXICOLOGY, 2021, 59 (01) : 70 - 71